It appears the DREAM-HF trial definitely presents a conundrum for the FDA.
Your probably right but it sickens me that a “conundrum” is what the FDA may find themselves in.
If a trial with the magnitude of Dream HF was run by a large pharma testing a pharmaceutical (with side affects of course) with the same results they would be touted as heros and have a blockbuster treatment approved straight off the bat.
What a joke.
Cell Therapy News/Articles, page-12479
-
- There are more pages in this discussion • 5,961 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.54 | $1.48 | $5.605M | 3.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 55197 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 29782 | 3 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |